Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.
Arcand SL, Maugard CM, Ghadirian P, Robidoux A, Perret C, Zhang P, Fafard E, Mes-Masson AM, Foulkes WD, Provencher D, Narod SA, Tonin PN.
Arcand SL, et al. Among authors: ghadirian p.
Breast Cancer Res Treat. 2008 Apr;108(3):399-408. doi: 10.1007/s10549-007-9608-6. Epub 2007 May 31.
Breast Cancer Res Treat. 2008.
PMID: 17541742